Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryce M Warner

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2022
Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1Gina M Cusimano, Ebony N Gary, Matthew R Bell, et al.
Biomedicines|September 28, 2021
Safety and Tolerability of the Adeno-Associated Virus Vector, AAV6.2FF, Expressing a Monoclonal Antibody in Murine and Ovine Animal ModelsAmira D Rghei, Laura P van Lieshout, Benjamin M McLeod, et al.
Vaccines|April 27, 2024
Mucosal Vaccination with a Newcastle Disease Virus-Vectored Vaccine Reduces Viral Loads in SARS-CoV-2-Infected Cynomolgus MacaquesBryce M Warner, Mable Chan, Nikesh Tailor, et al.
Frontiers in Immunology|March 31, 2023
Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challengeEbony N Gary, Nicholas J Tursi, Bryce M Warner, et al.
Nature Communications|June 15, 2021
SARS-CoV-2 infection and transmission in the North American deer mouseBryan D Griffin, Mable Chan, Nikesh Tailor, et al.
Iscience|June 14, 2021
A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogensEbony N Gary, Bryce M Warner, Elizabeth M Parzych, et al.
Iscience|December 6, 2021
Host parameters and mode of infection influence outcome in SARS-CoV-2-infected hamstersBryan D Griffin, Bryce M Warner, Mable Chan, et al.
Iscience|October 11, 2021
Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and diseaseBryce M Warner, Lisa A Santry, Alexander Leacy, et al.
Nature Communications|October 6, 2022
DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2Elizabeth M Parzych, Jianqiu Du, Ali R Ali, et al.
Plos Pathogens|February 19, 2026
Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralizationKylie M Konrath, Kevin Liaw, Nicholas J Tursi, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2022
Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1Gina M Cusimano, Ebony N Gary, Matthew R Bell, et al.
Biomedicines|September 28, 2021
Safety and Tolerability of the Adeno-Associated Virus Vector, AAV6.2FF, Expressing a Monoclonal Antibody in Murine and Ovine Animal ModelsAmira D Rghei, Laura P van Lieshout, Benjamin M McLeod, et al.
Vaccines|April 27, 2024
Mucosal Vaccination with a Newcastle Disease Virus-Vectored Vaccine Reduces Viral Loads in SARS-CoV-2-Infected Cynomolgus MacaquesBryce M Warner, Mable Chan, Nikesh Tailor, et al.
Frontiers in Immunology|March 31, 2023
Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challengeEbony N Gary, Nicholas J Tursi, Bryce M Warner, et al.
Nature Communications|June 15, 2021
SARS-CoV-2 infection and transmission in the North American deer mouseBryan D Griffin, Mable Chan, Nikesh Tailor, et al.
Iscience|June 14, 2021
A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogensEbony N Gary, Bryce M Warner, Elizabeth M Parzych, et al.
Iscience|December 6, 2021
Host parameters and mode of infection influence outcome in SARS-CoV-2-infected hamstersBryan D Griffin, Bryce M Warner, Mable Chan, et al.
Iscience|October 11, 2021
Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and diseaseBryce M Warner, Lisa A Santry, Alexander Leacy, et al.
Nature Communications|October 6, 2022
DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2Elizabeth M Parzych, Jianqiu Du, Ali R Ali, et al.
Plos Pathogens|February 19, 2026
Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralizationKylie M Konrath, Kevin Liaw, Nicholas J Tursi, et al.
Pageof 5